Health Care & Life Sciences » Biotechnology | Alliqua BioMedical Inc.

Alliqua BioMedical Inc. | Mutual Funds

Mutual Funds that own Alliqua BioMedical Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Tekla Healthcare Investors
115,500
2.31%
0
0.03%
12/31/2017
Tekla Life Sciences Investors
49,500
0.99%
0
0.03%
12/31/2017
Vanguard Extended Market Index Fund
41,300
0.83%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
6,374
0.13%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
1,090
0.02%
0
0%
09/06/2018
Vanguard Total Stock Market Index Trust
664
0.01%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
439
0.01%
0
0%
07/31/2018
Vanguard Invt. Fds. ICVC - US Equity Index Fund
360
0.01%
0
0%
06/30/2018

About Alliqua BioMedical

View Profile
Address
1010 Stony Hill Road
Yardley Pennsylvania 19067
United States
Employees -
Website http://alliqua.com
Updated 09/14/2018
Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics.